Skip to main content

Table 2 Response per patient, as detected on [18F]DOPA and [68Ga]DOTA-TOC PET/CT

From: Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy

No

TTPa (months)

TTDb (months)

RECIST (1-year)

Total lesions (n = 89)

Total matched lesions (n = 52)

Total DOPA lesions (n = 79)

DOPA-only lesions (n = 27)

DOPA-only tumour size (mm, mean)

Total DOTA lesions (n = 62)

DOTA-TOC-only lesions (n = 10)

DOTA-only tumour size (mm, mean)

1

PR

10

8

10

2

42

8

0

40

2

18

PR

7

3

14

11

19

3

0

14

3

0

5

PD

8

7

8

1

27

7

0

25

4

SD

10

4

4

0

18

10

6

31

5

SD

18

6

17

11

25

7

1

28

6

15

SD

14

7

7

0

16

7

0

16

7

14

SD

7

6

7

1

23

6

0

24

8

7

27

PD

15

11

12

1

14

14

3

41

  1. PR, Partial response; PD, progressive disease; SD, stable disease
  2. aTime to progression, btime to death (counting from date of last cycle of PRRT)